Gary Bryan Hendler
Corporate Officer/Principal bij EISAI CO., LTD.
Oorsprong van het eerstegraads netwerk van Gary Bryan Hendler
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 62 | |
Eisai Ltd. (United Kingdom)
Eisai Ltd. (United Kingdom) Pharmaceuticals: MajorHealth Technology Eisai Ltd. (United Kingdom) is a pharmaceutical company based in Hatfield, UK. Part of Eisai Co., Ltd., Eisai Ltd. prioritizes patients and their families by continually improving the benefits that healthcare can provide. The British company was founded in 1988 and Gary Bryan Hendler has been the CEO of the company since 2008.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
Eisai Farmacéutica SA
Eisai Farmacéutica SA Pharmaceuticals: MajorHealth Technology Eisai Farmacéutica SA is a pharmaceutical company based in Madrid, Spain. Eisai Farmacéutica SA operates as a Spanish pharmaceutical company. Part of Eisai Co., Ltd., the company was founded in 2001. The CEO is Gary Bryan Hendler.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Eisai GmbH
Eisai GmbH Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., Eisai GmbH is a German pharmaceutical company that specializes in research and development of innovative treatments for neurological and oncological diseases. The company is based in Frankfurt, Germany. The CEOs of the company are Gary Bryan Hendler, Nicholas Conrad Burgin.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Gary Bryan Hendler via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
AMGEN INC. | Pharmaceuticals: Major | Sales & Marketing | |
STANDEX INTERNATIONAL CORPORATION | Electronic Equipment/Instruments | Director of Finance/CFO | |
Veranova LP | Corporate Officer/Principal | ||
MERSANA THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
Thunderbird School of Global Management | College/University | Graduate Degree | |
OPIANT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
PENTAIR PLC | Industrial Machinery | Comptroller/Controller/Auditor | |
Duke University
Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree Undergraduate Degree | |
MURATA MANUFACTURING CO., LTD | Electronic Production Equipment | Director/Board Member | |
NTT DATA CORPORATION | Miscellaneous Commercial Services | President Director/Board Member | |
DAIWA SECURITIES GROUP INC. | Investment Banks/Brokers | Director/Board Member | |
SHOWA SHELL SEKIYU KK | Oil Refining/Marketing | Director/Board Member | |
MITSUBISHI SHOKUHIN CO., LTD. | Food Distributors | Director/Board Member Director/Board Member | |
NISSUI CORPORATION | Food: Meat/Fish/Dairy | Director/Board Member | |
PIGEON CORPORATION | Household/Personal Care | Director/Board Member | |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer Chief Executive Officer | |
IDEMITSU KOSAN CO., LTD. | Oil Refining/Marketing | Director/Board Member | |
University of California, Los Angeles | College/University | Masters Business Admin | |
Brandeis University | College/University | Doctorate Degree | |
University of Bridgeport | College/University | Undergraduate Degree | |
University of Massachusetts | College/University | Graduate Degree | |
INOVIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
AVEO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
TECHMATRIX CORPORATION | Information Technology Services | Director/Board Member | |
University of Hitotsubashi | College/University | Undergraduate Degree | |
Meiji University | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Japan Association of Corporate Executives | Corporate Secretary | ||
Sunplanet Co., Ltd.
Sunplanet Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Eisai Co., Ltd., Sunplanet Co., Ltd. is a Japanese company that provides facility management, pharmaceutical analysis, and research development services. The company is based in Tokyo, Japan and was founded in 2001. | Miscellaneous Commercial Services | Director/Board Member President | |
MEGMILK SNOW BRAND CO.,LTD. | Food: Meat/Fish/Dairy | Director/Board Member | |
Pacific Consultants Co., Ltd.
Pacific Consultants Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Pacific Consultants Co., Ltd. provides integrated construction consulting services in engineering and infrastructure design. Its services include the land conservation, transport infrastructure, facility engineering, public management, information systems, project planning, energy and environment, geotechnical, business development, research and development; and others. The company was founded on September 4, 1951 and is headquartered in Tokyo, Japan. | Miscellaneous Commercial Services | Director/Board Member | |
SOMPO HOLDINGS INC. | Multi-Line Insurance | Director/Board Member | |
Eisai R&D Management Co., Ltd.
Eisai R&D Management Co., Ltd. BiotechnologyHealth Technology Part of Eisai Co., Ltd., Eisai R&D Management Co., Ltd. engages in research and development of pharmaceuticals. The company is based in Bunkyo, Japan. | Biotechnology | President President | |
H3 Biomedicine, Inc.
H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa. | Pharmaceuticals: Major | President Chief Executive Officer Chief Executive Officer | |
SCSK CORPORATION | Miscellaneous Commercial Services | Director/Board Member | |
PUMA BIOTECHNOLOGY, INC. | Pharmaceuticals: Major | Director/Board Member | |
Japanese Chamber of Commerce & Industry of New York, Inc.
Japanese Chamber of Commerce & Industry of New York, Inc. Miscellaneous Commercial ServicesCommercial Services Japanese Chamber of Commerce Industry of New York, Inc. is non-profit organization that engages in facilitation of trade between the U.S. and Japan. The company was founded on November 14, 1932 by 14 prominent Japanese businessman, and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member | |
Harvard Business School | College/University | Masters Business Admin | |
Duke University School of Medicine | College/University | Doctorate Degree | |
StandexMeder Electronics GmbH
StandexMeder Electronics GmbH Electrical ProductsProducer Manufacturing Part of Standex International Corp., StandexMeder Electronics GmbH designs, manufactures and markets reed switches, relays, sensors and other products. The company is based in Singen, Germany. The CEOs of the German company are John Meeks, Ademir Sarcevic, Rainer Hombeck. | Electrical Products | Chief Executive Officer | |
N4 PHARMA PLC | Biotechnology | Chief Tech/Sci/R&D Officer | |
Russell Reynolds Associates Japan, Inc. | Director/Board Member | ||
Eisai Europe Ltd.
Eisai Europe Ltd. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., Eisai Europe Ltd. is a British pharmaceutical company that manufactures and distributes pharmaceutical products. The company is based in Hatfield, UK and was founded in 2004. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Miura & Partners
Miura & Partners Miscellaneous Commercial ServicesCommercial Services Miura & Partners is a law office that provides the best results to clients. The private company is based in Tokyo, Japan. The Japanese company has a team of experienced lawyers and staff who utilize their knowledge and know-how to serve their clients effectively. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Nextpoint Therapeutics, Inc.
Nextpoint Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nextpoint Therapeutics, Inc. is a biotech company based in Cambridge, MA. The company is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. The company's innovative approach integrates foundational science with a defined clinical biomarker to deliver a new class of monotherapies for patients who will not benefit from PD-1/L1 inhibitors. Nextpoint Therapeutics has assembled a team of proven drug developers to build a broad strategic pipeline of first-in-class immunotherapies. Detlev Biniszkiewicz has been the CEO of the company since 2018. | Miscellaneous Commercial Services | Chief Executive Officer | |
Brianplant Holdings Ltd.
Brianplant Holdings Ltd. Financial ConglomeratesFinance Brianplant Holdings Ltd. is an investment holding British company founded in 2018. The private company is based in North East Lincolnshire, UK. The company's main function is to hold investments. | Financial Conglomerates | Director/Board Member | |
ALLENA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Eisai Manufacturing Ltd.
Eisai Manufacturing Ltd. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., Eisai Manufacturing Ltd. is a pharmaceutical company based in Hatfield, UK. The British company's focus is on developing new medicines for neglected tropical diseases and malaria, improving access to medicines for non-communicable diseases, and promoting sustainability. Eisai Manufacturing is committed to funding the 3rd phase of health innovative technology fund activities. The company's official corporate website provides information on their initiatives and HHC concept. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member |
Statistieken
Internationaal
Verenigde Staten | 23 |
Japan | 21 |
Verenigd Koninkrijk | 6 |
Zwitserland | 2 |
Frankrijk | 2 |
Sectoraal
Health Technology | 16 |
Consumer Services | 11 |
Commercial Services | 9 |
Finance | 4 |
Consumer Non-Durables | 4 |
Operationeel
Director/Board Member | 117 |
Corporate Officer/Principal | 54 |
Independent Dir/Board Member | 49 |
President | 23 |
Chairman | 17 |
Sterkste connecties
- Beurs
- Insiders
- Gary Bryan Hendler
- Bedrijfsconnecties